MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0011449
Sarcoma Remedies Private Limited - pharma in Manimajra, Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.65 Cr
▼ 10% YoY
Net profit · FY 2025
₹7.07 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹10.94 Lakh
EBITDA margin 3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Sarcoma Remedies Private Limited
Data last updated:
Sarcoma Remedies Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH2015PTC035704. Its GSTIN is 04AAWCS1438D1ZC (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Swarn Singh and Ankit Kumar.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 1027 Basement And Ground Floor Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.65 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹7.07 Lakh (net margin 1.9%) and EBITDA of ₹10.94 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 4% over five years.
Court records list 4 cases involving the company, including 4 filed by the company.
Sarcoma Remedies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0011449). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sarcomaremedies.com.
Company details
CIN U24239CH2015PTC035704
Registration Number 035704
Incorporation Date 21 August 2015
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0011449
Recognitions & Rankings of Sarcoma Remedies
Contact details
Sarcoma Remedies Private Limited's registered office is in Manimajra, Chandigarh. Its website is sarcomaremedies.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf 1027 Basement And Ground Floor Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sarcoma Remedies Private Limited, buy the company report.
Comprehensive company report
Sarcoma Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sarcoma Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sarcoma Remedies Private Limited, buy the company report.
Financials of Sarcoma Remedies Private Limited
FY 2025 filings availableSarcoma Remedies Private Limited reported revenue of ₹3.65 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹3.65 Cr ▼ 10%
Net profit · FY 2025
₹7.07 Lakh margin 1.9%
EBITDA · FY 2025
₹10.94 Lakh margin 3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 3%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 14%
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sarcoma Remedies Private Limited, buy the company report.
Board of directors of Sarcoma Remedies Private Limited
Sarcoma Remedies has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swarn Singh Also directs: Jayden Healthcare Private Limited, Medimore Healthcare Private Limited, Acekinetics Healthcare Private Limited and 1 more | Director | 21 Aug 2015 | 11 Years 2 Months | Current |
| Ankit Kumar | Director | 11 Feb 2021 | 5 Years 8 Months | Current |
| Narendra Kumar | Director | 21 Aug 2015 | 11 Years 2 Months | Current |
Auditor
Sarcoma Remedies Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2020 | 018361N |
Shareholding
The shareholding of Sarcoma Remedies Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sarcoma Remedies Private Limited, buy the company report.
Legal cases
Sarcoma Remedies Private Limited has 4 court cases on record: 4 filed by Sarcoma Remedies. All cases are disposed.
Total cases
4
Filed by the company
4
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Maa Durga Drug Distributor and 2 others | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Concern Inc and 1 other | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Shiv Medical Agencies and 1 other | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S SS Pharmaceuticals and Surgicals and 1 other | Disposed |
To see the full case history of Sarcoma Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarcoma Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sarcoma Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAWCS1438D1ZC | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sarcoma Remedies Private Limited, buy the company report.
Recent activity
Sarcoma Remedies Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Ankit Kumar ceased to be Additional Director on 30 Nov 2021.
AGM
Sarcoma Remedies Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Filing
Sarcoma Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Ceased
Ankit Kumar ceased to be Additional Director.
Appointed
Ankit Kumar was appointed as Director.
Appointed
Narendra Kumar was appointed as Director.
Appointed
Swarn Singh was appointed as Director.
Incorporation
21 Aug 2015
Sarcoma Remedies Private Limited was registered on 21 Aug 2015 with Roc Chandigarh & aged 11 years 2 months as per MCA records.
Frequently asked questions
Sarcoma Remedies is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 August 2015 (11+ years old) and is registered under CIN U24239CH2015PTC035704.
Sarcoma Remedies has 3 current directors:
- Swarn Singh - Director
- Ankit Kumar - Director
- Narendra Kumar - Director
The latest financial statements of Sarcoma Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sarcoma Remedies is 04AAWCS1438D1ZC, registered in Chandigarh.
The CIN (Corporate Identification Number) of Sarcoma Remedies is U24239CH2015PTC035704. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarcoma Remedies has 4 court cases on record: 4 filed by the company.
Sarcoma Remedies was incorporated on 21 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chandigarh.
Ankit Kumar ceased to be Additional Director on 30 Nov 2021. Ankit Kumar was appointed as Director on 11 Feb 2021. Narendra Kumar was appointed as Director on 21 Aug 2015. Sarcoma Remedies has 4 board changes on record in total.
Yes, Sarcoma Remedies is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0011449).
Sarcoma Remedies can be reached through the website sarcomaremedies.com. Its registered office is in Manimajra, Chandigarh, India.